InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Wheeler Craig A, Director. Officer active across 4 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 10 disclosures have been published. Activity tracked since 10 June 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wheeler Craig A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
24,444 sharesCommon StockSEC:0001193125-26-224585:0
84,631 shares@ US$14.500.026% mcap100.0% of flowCommon StockSEC:0001193125-26-182285:0
7,961 shares0Common StockSEC:0001492422-26-000008:0
20,414 shares0Common StockSEC:0000950170-25-083196:0
16,483 shares0Common StockSEC:0001127602-25-012384:0
11,847 shares0Common StockSEC:0000950170-24-071009:0
8,584 shares0Common StockSEC:0001209191-23-036412:0
12,671 shares0Common StockSEC:0001209191-22-035857:0
10,115 shares0Common StockSEC:0001209191-21-040379:0
63,000 sharesCommon StockSEC:0001179110-16-018968:0
10 of 10 declarations
About Wheeler Craig A
Craig A. Wheeler is a Director at Apellis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. He brings expertise in management and business strategy to the boards. His role is essential in guiding strategic decisions and ensuring the sustainable growth of the companies.
